HALO:BMV
Halozyme Therapeutics, Inc.
MX$1,955.00
arrow_downward
-0.70%(-13.69) 1D
Oct 1, 1:46:16 PM GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HALO...
Mkt. cap
13.26B
Avg. vol.
440.00
Volume
0.00
52-wk high
MX$1,970.00
52-wk low
MX$1,126.00
No. of employees
423
Mkt. cap
13.26B
Avg. vol.
440.00
Volume
0.00
52-wk high
MX$1,970.00
52-wk low
MX$1,126.00
No. of employees
423
News stories
From web sources and news partners
Simply Wall Street
·
49 minutes ago
Halozyme Stock Has The Bull Case Changed After Argenx Deal Expansion?
StocksToTrade
·
1 hour ago
HALO Stock Climbs As Patent Win Fuels Bullish Targets
Timothy Sykes
·
1 hour ago
HALO Stock Climbs As Patent Win And Targets Fuel Momentum
StocksToTrade
·
3 hours ago
HALO Stock Rallies As Patent Wins Boost Settlement Hopes
Profile
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
About Halozyme Therapeutics, Inc.
CEOHelen I. Torley
Employees423
Founded1998
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websitehalozyme.com